← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS). (2021/12/11) ♡
• Hepatitis C infection and chronic kidney disease among Hispanics/Latinos. (2021/12/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis. (2021/12/10) ♡
• Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China. (2021/12/09) ♡
• Oxidative Stress Induces Mitochondrial Compromise in CD4 T Cells From Chronically HCV-Infected Individuals. (2021/12/08) ♡
• Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma. (2021/12/07) ♡
• A population-based US study of hepatitis C diagnosis rate. (2021/12/01) ♡
• The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes. (2021/12/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. (2021/12/01) ♡
• Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C: Current State of Treatment in Children. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [The Current Status and Research Progress of Antiviral Therapy in HCV-Associated Lymphoma --Review]. (2021/12/01) ♡
• Effects of direct-acting antiviral therapy for patients with advanced hepatocellular carcinoma and concomitant hepatitis C-A population-based cohort study. (2021/12/01) ♡
• Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients. (2021/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatitis C Virus is Treatable but We Need to Be Sure of a Cure. (2021/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow. (2021/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study. (2021/12/01) ♡
• Assessment of outcome for sample of Iraqi patients with chronic hepatitis C virus infection treated by Ledipasvir/sofosbuvir drug. (2021/12/01) ♡
• Chemokine receptor CXCR6 gene polymorphism and treatment response of chronic hepatitis C virus in Egyptian patients. (2021/12/01) ♡
• Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections. (2021/12/01) ♡
• DEPRESSION, ANXIETY AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION IN VOJVODINA. (2021/12/01) ♡
• Assessment of pathomorphological characteristics of the oral mucosa in patients with HBV, HCV and HIV. (2021/11/30) ♡
• Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. (2021/11/27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]. (2021/11/20) ♡
• Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis. (2021/11/20) ♡
• Inflammation and Liver Cell Death in Patients with Hepatitis C Viral Infection. (2021/11/16) ♡
• Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. (2021/11/12) ♡
• Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy. (2021/11/01) ♡
• Prevalence of hepatitis E infection among adults with concurrent chronic liver disease. (2021/11/01) ♡
• Effectiveness of Sofosbuvir and Daclatasvir in treatment of Hepatitis-C: An experience of tertiary care hospital in Karachi. (2021/11/01) ♡
• miR-155 regulates pro- and anti-inflammatory cytokine expression in human monocytes during chronic hepatitis C virus infection. (2021/11/01) ♡
• Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40. (2021/11/01) ♡
• APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection. (2021/11/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs. (2021/10/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A challenging case of pyrexia of unknown origin: adrenal histoplasmosis mimicking tuberculosis in a patient with chronic hepatitis C. (2021/10/01) ♡
• Hepatitis C outbreak in a respiratory care ward associated with frequent injections: Taiwan, 2017. (2021/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology. (2021/10/01) ♡
• The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. (2021/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply - Letter to the editor - Derivation and validation of a simple anthropometric equation to predict fat-free mass in patients with chronic hepatitis C. (2021/10/01) ♡
• NON-ADHERENCE TO HEPATITIS C TREATMENT: A BRAZILIAN REPORT. (2021/10/01) ♡
• MAJOR DEPRESSIVE DISORDER IS ASSOCIATED WITH TYPE 2 DIABETES IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION. (2021/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Worldwide prevalence, genotype distribution and management of hepatitis C. (2021/10/01) ♡
• [Improvement of clinical course of liver cirrhosis due to chronic hepatitis C after successful treatment with direct acting antivirals]. (2021/10/01) ♡
• Adherence to a Fish-Rich Dietary Pattern Is Associated with Chronic Hepatitis C Patients Showing Low Viral Load: Implications for Nutritional Management. (2021/09/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Tuberculosis of the chest wall: Report of a case at the Joseph Ravoahangy Andrianavalona Teaching Hospital, Antananarivo, Madagascar]. (2021/09/23) ♡
• [Efficacy and tolerance of direct-acting antiviral drugs for the treatment of hepatitis C in Joseph Raseta Befelatanana Teaching Hospital in Antananarivo, Madagascar]. (2021/09/16) ♡
• The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results. (2021/09/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review. (2021/09/11) ♡
• Impact of sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimens on the male sexual function of patients with chronic hepatitis C. (2021/09/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress and Barriers Towards Elimination of Chronic Hepatitis C in Children. (2021/09/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.